Laurent Chardonnet
No más puestos en curso
Fortuna: 193 738 $ al 31/03/2024
Perfil
Laurent Chardonnet served as Treasurer, Principal Accounting Officer & VP at Incyte Corp.
from 2004 to 2015.
Prior to that, he was Vice President-Finance at DrugAbuse Pharmaceutical, Inc. from 2000 to 2004.
He also worked as a Senior Consultant at PricewaterhouseCoopers LLP and as Chief Financial Officer, Controller & VP at Drugabuse Sciences, Inc. Mr. Chardonnet's most recent position was Chief Financial Officer & Senior Vice President at Axcella Health, Inc. from 2019 to 2021.
Currently, he is serving as the Chief Financial & Accounting Officer at Prelude Therapeutics, Inc. starting from 2021.
Mr. Chardonnet holds an MBA from Vanderbilt University and an undergraduate degree from Institut Supérieur de Gestion.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/03/2024 | 40 873 ( 0.07% ) | 193 738 $ | 31/03/2024 |
Antiguos cargos conocidos de Laurent Chardonnet.
| Empresas | Cargo | Fin |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Director of Finance/CFO | 08/04/2024 |
| AXCA HEALPAR | Director of Finance/CFO | 28/11/2021 |
DrugAbuse Pharmaceutical, Inc.
 DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Director of Finance/CFO | 01/01/2004 |
| Drugabuse Sciences, Inc. | Director of Finance/CFO | - |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | - |
Formación de Laurent Chardonnet.
| Vanderbilt University | Masters Business Admin |
| Institut Supérieur de Gestion | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| AXCA HEALPAR | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Empresas privadas | 3 |
|---|---|
DrugAbuse Pharmaceutical, Inc.
DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
| Drugabuse Sciences, Inc. |
- Bolsa de valores
- Insiders
- Laurent Chardonnet
